ASX:CYC

Cyclopharm Stock Forecast, Price & News

Add

Compare

Today's Range N/A

50-Day Range N/A

52-Week Range N/A

Volume10,000 shs

Average VolumeN/A

Market CapitalizationN/A

P/E RatioN/A

Dividend Yield0.52%

BetaN/A

Receive CYC News and Ratings via Email

Sign-up to receive the latest news and ratings for Cyclopharm and its competitors with MarketBeat's FREE daily newsletter.

About Cyclopharm

Cyclopharm Limited engages in the research and development, manufacture, and sale of medical equipment and radiopharmaceuticals in the Asia Pacific, Europe, Canada, and internationally. The company operates through Technegas and Molecular Imaging segments. It offers diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism. The company also provides radiopharmaceuticals that are used by physicians in the detection of cancer, neurological disorders, and cardiac diseases. It serves nuclear medicine departments. Cyclopharm Limited was founded in 1986 and is headquartered in Kingsgrove, Australia.

The Cyclopharm Limited (ASX:CYC) Analyst Just Boosted Their Forecasts By A Substantial Amount
March 1, 2021 | finance.yahoo.com

Do Institutions Own Cyclopharm Limited (ASX:CYC) Shares?
February 23, 2021 | finance.yahoo.com

We're Hopeful That Cyclopharm (ASX:CYC) Will Use Its Cash Wisely
December 16, 2020 | finance.yahoo.com

Shareholders Of Cyclopharm (ASX:CYC) Must Be Happy With Their 293% Total Return
November 1, 2020 | finance.yahoo.com

Why the Cyclopharma (ASX:CYC) share price surged to record high today
September 17, 2020 | msn.com

How Much Of Cyclopharm Limited (ASX:CYC) Do Insiders Own?
September 16, 2020 | finance.yahoo.com

Oral Care/Hygiene Market Expected to Surpass $53 Billion by 2025
July 26, 2020 | finance.yahoo.com

Cyclopharm Limited's (ASX:CYC) Path To Profitability
July 23, 2020 | finance.yahoo.com

Should You Worry About Cyclopharm Limited's (ASX:CYC) CEO Pay?
July 22, 2020 | finance.yahoo.com

We Think Cyclopharm (ASX:CYC) Can Easily Afford To Drive Business Growth
July 22, 2020 | finance.yahoo.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange ASX
Industry Medical Devices
Sub-IndustryN/A
SectorMedical
Current SymbolASX:CYC
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.cyclopharm.com.au
Phone61 2 9541 0411
EmployeesN/A
Year FoundedN/A

Sales & Book Value

Annual Sales$20.39 million
Price / Sales0.00
Cash FlowN/A
Price / Cash Flow8.40
Book ValueA$0.48 per share
Price / BookN/A

Profitability

Debt

Price-To-Earnings

Miscellaneous

Outstanding SharesN/A
Market CapN/A
Next Earnings DateN/A
OptionableNot Optionable

MarketRank^™

Overall MarketRank^™

0.83 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Cyclopharm.

4.1 Community Rank

Outperform Votes
Cyclopharm has received 10 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Cyclopharm has received 6 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Cyclopharm has received 62.50% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Cyclopharm and other stocks. Vote “Outperform” if you believe CYC will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CYC will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Cyclopharm has a dividend yield of 0.52%, which is in the bottom 25% of all stocks that pay dividends.
Dividend Growth
Cyclopharm does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Cyclopharm insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

Cyclopharm (ASX:CYC) Frequently Asked Questions

What stocks does MarketBeat like better than Cyclopharm?

Wall Street analysts have given Cyclopharm a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Cyclopharm wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How often does Cyclopharm pay dividends? What is the dividend yield for Cyclopharm?

Cyclopharm declared a Interim dividend on Tuesday, August 24th. Stockholders of record on Sunday, September 12th will be paid a dividend of 0.005 per share on Sunday, September 12th. This represents a dividend yield of 0.3%. The ex-dividend date of this dividend is Thursday, September 2nd.
View Cyclopharm's dividend history.

Is Cyclopharm a good dividend stock?

Cyclopharm pays an annual dividend of A$0.01 per share and currently has a dividend yield of 0.52%.
View Cyclopharm's dividend history.

Who are Cyclopharm's key executives?

Cyclopharm's management team includes the following people:

Mr. James S. McBrayer F.A.C.I.D., BSPharm, GDM, FAICD, AIM, CEO, MD, Company Sec. & Director (Age 56, Pay $535.93k)
Mr. Mathew Farag, Chief Operating Officer
Mr. Graham N. Phillips, Fin. Mang.
Dr. Mark Doverty, Global Head of Regulatory Compliance & Clinical Research
Ms. Sally-Ann Cornelius, Head of Sales
Ms. Niamh McAree, Head of Quality and Regulatory
Mr. Chris Quinn, Head of Service
Ms. Sui Ling Cheah, Financial Controller (Age 51)
Mr. Lynn McLauchlin, Gen. Mang. of Canada
Mr. Gary T. Somerville, Quality & Regulatory Mang.

Who are some of Cyclopharm's key competitors?

Some companies that are related to Cyclopharm include 4DMedical (4DX), Adherium (ADR), ADM Tronics Unlimited (ADMT), Allegra Orthopaedics (AMT), Analytica (ALT), AnteoTech (ADO), Anteris Technologies (AVR), Asensus Surgical (ASXC), Atomo Diagnostics (AT1), AVITA Medical (AVH), Azure Healthcare Limited (AZV.AX) (AZV), Cannabix Technologies (BLO), CleanSpace (CSX), Cochlear (COH) and Cochlear (CHEOY).
View all of CYC's competitors.

What is Cyclopharm's stock symbol?

Cyclopharm trades on the ASX under the ticker symbol "CYC."

How much money does Cyclopharm make?

Cyclopharm has a market capitalization of $0.00 and generates $20.39 million in revenue each year.

How many employees does Cyclopharm have?

Cyclopharm employs 48 workers across the globe.

What is Cyclopharm's official website?

The official website for Cyclopharm is www.cyclopharm.com.au.

How can I contact Cyclopharm?

The company can be reached via phone at 61 2 9541 0411.

This page was last updated on 9/23/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Cyclopharm Stock Forecast, Price & News

About Cyclopharm

Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

MarketRank™

Overall MarketRank™

0.0 Analyst's Opinion

Consensus Rating

4.1 Community Rank

Outperform Votes

Underperform Votes

Community Sentiment